Trial NCT01416181

View at ClinicalTrials.gov 
Org. Study IDs: 101MS326
Secondary IDs: 2010-021978-11

Last trial update was posted on 2017-09-11

MeSH Interventions

Natalizumab

MeSH Conditions

Multiple Sclerosis Multiple Sclerosis, Chronic Progressive Neoplasm Metastasis Sclerosis

Other Conditions

Secondary Progressive Multiple Sclerosis

Stopping Reasons

The ASCEND Study did not achieve statistical significance on the primary or secondary endpoints.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID